Alzamend Neuro has an EPS of $-2.25. In 2022, the company made an earnings per share (EPS) of $-2.1. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$2.25 | 7.14% |
2022 | -$2.10 | 135.61% |
2021 | -$0.89131 | 20.94% |
2020 | -$0.736981 | - |